drugset / Trial / NCT05259527
Vitamin D Supplementation on Reported Rates of Taxane-Induced Neuropathy
RandomizedParallel-groupSingle-blindSupportive care
Summary
This is a two-arm randomized clinical trial in which 80 participants with Vitamin D deficiency and scheduled to begin taxane-based chemotherapy will be randomized to either: 1) prescribed vitamin D replacement or 2) standard of care.
Timeline
- Start
- 2022-12-19
- Primary completion
- 2030-03-31
- Completion
- 2030-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ergocalciferol | Small molecule | 50000 iu | Oral |